| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |